Trump signs executive measures for pandemic relief, but effects are unclear.
President Trump took executive action this weekend that he said would extend an array of federal pandemic relief, while the United States reached yet another virus milestone: five million cases.
It was not clear, though, what immediate effect the orders he signed would have, if any, or what authority Mr. Trump has to act on his own. Under the Constitution, Congress has control over federal spending, and it appears likely that Mr. Trumps moves to circumvent Congress will be challenged in court.
Mr. Trump signed the orders billed as a federal eviction ban, a payroll tax suspension, relief for student borrowers and $400 a week for the unemployed at a news conference at his private golf club in New Jersey on Saturday. The orders did not include a number of provisions sought in congressional proposals, like aid to small businesses, school systems, and state and local governments.
The action came after two weeks of talks between White House officials and top congressional Democrats failed to reach agreement on a broad relief plan and temporary benefits provided under earlier aid measures expired with no resolution in sight.
Virus cases have surged in recent weeks, particularly in the Sun Belt states and in communities where officials moved quickly to reopen. But the nascent economic recovery from those reopenings has appeared to slow or stall in many areas. And schools across the country are grappling with how and whether to reopen in the fall.
According to a New York Times database, the U.S. leads the world in confirmed cases. Brazil ranks second, with more than three million confirmed cases, and India is third with two million. Public health experts have warned that the actual number of people infected is far greater. Brazil also reached a milestone of 100,000 deaths on Saturday.
At least 161,900 people infected with the virus have died in the U.S. since the pandemic began.
New Zealand on Sunday marked 100 days without any new reported cases of local transmission of the coronavirus, a major milestone as the pandemic continues to devastate countries across the world including neighboring Australia, where recent outbreaks have led to new lockdown measures in Melbourne and broader Victoria State.
New Zealand, a nation of five million people, reported in March that it had stamped out the virus after strict lockdown measures were implemented, and there has been no community transmission since, according to the countrys Health Ministry.
It has been 100 days since the last case of Covid-19 was acquired locally from an unknown source, the ministry said in a statement on Sunday. No additional cases are reported as having recovered, so there are still 23 active cases of Covid-19 in managed isolation facilities.
Public life has resumed for many people in the country, as they eat out at restaurants, socialize at bars, and attend sports and cultural events. However, some experts warn that letting down their guard now could lead to future outbreaks.
Achieving 100 days without community transmission is a significant milestone, said Dr. Ashley Bloomfield, the countrys top health official, said in a statement on Sunday. However, as we all know, we cant afford to be complacent.
We have seen overseas how quickly the virus can re-emerge and spread in places where it was previously under control, he said, and we need to be prepared to quickly stamp out any future cases in New Zealand.
Eight months ago, the new coronavirus was unknown. But to some human immune cells, it was already something of a familiar foe.
A flurry of recent studies has revealed that a large proportion of the population in some places, 20 to 50 percent of people might harbor immunity assassins called T cells that recognize the new coronavirus despite having never encountered it before.
These T cells, which lurked in the bloodstreams of people long before the pandemic began, are most likely stragglers from past scuffles with other related coronaviruses, including four that frequently cause common colds. Its a case of family resemblance: In the eyes of the immune system, germs with common roots can look alike, such that when a cousin comes to call, the body may already have an inkling of its intentions.
The presence of these T cells has intrigued experts, who say it is too soon to tell whether the cells will play a helpful, harmful or entirely negligible role against the current coronavirus.
But should these cross-reactive T cells exert even a modest influence on the bodys immune response, they might make the disease milder and perhaps partly explain why some people who catch the germ become very sick while others are dealt only a glancing blow.
Radhika Kumar goes to work every morning hoping to save lives. As a contact tracer for Los Angeles County, her job, at least on paper, entails phoning people who have tested positive for the coronavirus, along with others they may have exposed, and providing them with guidance on how to isolate so as not to infect others.
If that sounds easy, it is not.
To persuade people to cooperate, she has to get them to trust her. She has to convince them that they might be infected, even if they have no symptoms. She has to let people curse at her and hang up, then she has to call them back the next day.
And if she wants them to heed her advice, she has to listen, really listen, to how scared they are that if they stay home from their jobs, they might not be able to feed their families.
Sometimes it can really get to you, she said. The other day I had one young lady, and she was screaming on the phone, You dont understand I have three kids. I have to go to work.
I kept calling back and calling back, Ms. Kumar said. Im very relentless like that. I thought about it all night what am I going to do? I called her again first thing in the morning, and I was so relieved when she picked up.
Even as officials at the Centers for Disease Control and Prevention continue to tout the effectiveness of contact tracing, and state and local health agencies across the United States deploy new armies of tracers, tracking down everyone with the coronavirus is proving to be a Sisyphean task.
France is imposing a new requirement that people wear face masks outdoors in crowded areas of Paris and other major cities beginning on Monday as the number of coronavirus infections rises at the fastest rate since a national quarantine ended in mid-May.
The country had gotten the number of infections under control, but the pandemic is creeping back, with 2,288 new Covid-19 cases reported on Friday the third consecutive day of sharp increase. In the Paris Ile-de-France region, the rate of infections reached 2.4 percent on Friday, compared with a 1.6 percent national average.
The rise of new clusters has led the government to warn of the possibility of a second wave of infections in the autumn. In an effort to stem the spread of the virus, masks will now be mandatory for people age 11 and above in high-traffic areas, from the tourist havens of Saint Tropez and Biarritz to Pariss Seine river, Montmartre and other popular sites, as well as at outdoor food markets and in Pariss crowded suburbs.
The police will be enforcing the measures which will be in place for at least a month in Paris and are subject to review in other areas with a fine of 135 euros ($159).
The authorities are especially concerned about the popularity of free parties, that have seen hundreds of young people gather in the Parisien woods and other areas, often without wearing masks.
Wearing a mask in crowded enclosed spaces, including museums, shopping malls and on public transportation, has been compulsory in France since mid-July.
Tens of thousands of motorcyclists swarmed the streets of Sturgis, S.D., in the past few days for an annual rally, despite objections from residents and with little regard for the coronavirus.
The herds of people driving recreational vehicles, bikes and classic cars overran every street in town, making little or no effort to keep six feet apart. Few masks could be seen, and free bandannas being passed out were mostly folded, or wrapped around peoples heads.
With temperatures in the low 80s and not much cloud cover, many people sought shade under shopping tents where Screw Covid shirts were sold.
The Sturgis Motorcycle Rally, a 10-day affair that began Friday, is expected to attract roughly 250,000 enthusiasts this year about half the number who attended last year, but a figure that puts it on track to be among the countrys largest public gatherings since the first coronavirus cases emerged.
South Dakota is one of several states that did not impose a lockdown, and state officials have not required residents to wear masks.
Health experts say the coronavirus is less likely to spread outdoors, especially when people wear masks and socially distance. But large gatherings also increase the number of visitors inside restaurants and stores.
A few businesses in Sturgis put up signs limiting the number of customers who could enter, but most did not.
Over the past week, South Dakota has reported an average of 87 new coronavirus cases per day. At least two new virus deaths and 106 new cases were reported on Saturday.
In 2009, when H1N1, better known as swine flu, was stoking fears of a devastating pandemic, a small biotech company named Inovio Pharmaceuticals rushed to create a vaccine. After announcing promising early results, the companys stock soared more than 1,000 percent.
In the years since, Inovio has announced encouraging news about its work on vaccines for malaria, the Zika virus and even a cancer vaccine. The declarations have caused the companys stock price to leap, enriching investors and senior executives.
There is a catch, though: Inovio has never brought a vaccine to market.
Now, Inovio is working on a vaccine for the coronavirus, and a flurry of positive news releases about its funding and preliminary results have helped the company attract money from the U.S. government and investors.
But some scientists and financial analysts question the viability of Inovios technology. While there are some early signs of promise with its vaccine, Inovio has released only bare-bones data from the first phase of clinical trials. It is locked in a legal battle with a key manufacturing partner that claims Inovio stole its technology.
And while the company has said that it is part of Operation Warp Speed the flagship federal effort to quickly produce treatments and vaccines for the coronavirus Inovio is not on the list of companies selected to receive financial support to mass-produce vaccines.
The absence of that funding, coupled with their ongoing litigation, coupled with the need to scale a device, coupled with the absence of complete Phase 1 data, makes people skeptical, said Stephen Willey, an analyst at Stifel, an investment firm.
Inovio could provide an update on its progress with the vaccine when it releases its second-quarter financial results on Monday.
Saudi Aramco, the worlds largest oil company, said on Sunday that its quarterly earnings had plunged more than 73 percent compared with a year ago, as lockdowns imposed to curb the pandemic drastically cut the demand for oil. Despite the steep fall in earnings, to $6.6 billion from $24.7 billion, the company said it would continue paying a quarterly dividend of $18.75 billion nearly all of which will go to the Saudi government.
At least nine people were killed after a fire broke out on Sunday at a hotel in southern India that was being used as a makeshift facility for Covid-19 patients, officials said.
The fire, in the city of Vijayawada, occurred at the Swarna Palace hotel, which was being used to shelter and treat people who had tested positive for the coronavirus.
The police attributed the accident to a short circuit in an air-conditioner on the ground floor. After the blaze broke out early Sunday, panicked patients jumped from balconies on the upper floors and several were injured, according to local news media outlets.
After most of Indias coronavirus restrictions were lifted in recent weeks, infections have surged, leading some states to move patients into hotels and other makeshift health facilities. As of Sunday, Indias health ministry had reported more than two million total infections and nearly 45,000 deaths.
Despite surging coronavirus transmission rates around the United States, the N.F.L. contends that its season will begin, as scheduled, on Sept. 10. But 68 players have opted out of playing, according to the league.
They represent a microcosm of N.F.L. rosters: rookies and veterans, practice-squadders and starters, all of whom decided to lessen one risk while absorbing another. To keep themselves and their families safer, they will sacrifice the chance to compete for a Super Bowl, forgo showcasing themselves for more lucrative contracts and, in some cases, cede starting jobs and roster spots that may or may not be there next season.
Half of the players who opted out are offensive and defensive linemen, who are in closest contact with other players during practices and games. Leo Koloamatangi, an offensive lineman on the Jets who opted out, said he was resigned to contracting the virus had he chosen to play.
Where I play, Im literally bear-hugging another creature on the other side of the ball every single play, Koloamatangi, 26, said in an interview. If that guy has any symptoms, Im going to get them. He added, For myself, I couldnt take those chances.
Koloamatangi said he knew it was unfeasible for the N.F.L. to enter a bubble, as the N.B.A. and N.H.L. have. But he wondered why the N.F.L. had not pushed back camp and the season, or introduce additional safety measures such as gloves, or helmets with masks that would further mitigate his risk of infection.
As it stands, the N.F.L.s testing protocol calls for players to be tested every day for the first two weeks of training camp, and then every other day after that.
Reporting was contributed by Liz Alderman, David Gelles, Heather Murphy, Stanley Reed, Ben Shpigel, Derrick Taylor, Mark Walker, Katherine J. Wu and Ceylan Yeginsu.
Go here to read the rest:
Coronavirus Live Updates: Latest News and Analysis - The New York Times
- John Cleese says he's been spending 17,000 annually on stem cell therapy to 'buy a few extra years' - Yahoo News UK - April 24th, 2024
- Promethera Bets Liver-Derived Stem Cells Will Offer Benefits In NASH - Scrip - April 24th, 2024
- Stem Cell Therapies: Is This The Future Of Wellness? - Grazia USA - April 20th, 2024
- Signal of Benefit for Stem Cell Therapy in Progressive MS - Medscape - March 7th, 2024
- The Controversies Surrounding Stem Cell Therapy for Autism - The Portugal News - February 24th, 2024
- Benefits of Stem Cell Therapy - News Channel 5 Nashville - February 7th, 2024
- What is Stem Cell Therapy & How It Helps Others - Publicist Paper - January 31st, 2024
- A guide to stem cell therapy in Thailand - Thaiger - January 4th, 2024
- Half of pediatric patients with aHUS benefit from Soliris after... - AHUS News - December 21st, 2023
- Real world analysis on the determinants of survival in primary ... - Nature.com - December 5th, 2023
- The Best Beauty Gifts According To People Who Really Know Skin Care - HuffPost - December 5th, 2023
- The Eyepopping Factory Construction Boom in the US - WOLF STREET - December 3rd, 2023
- Benefit of Neoadjuvant Therapy Illustrated During ESMO Congress ... - Targeted Oncology - December 1st, 2023
- Benefits Outweigh Risks as FDA Inspects CAR-T Cell Therapy ... - Curetoday.com - December 1st, 2023
- Review What Real Cavityn Customers Say About Benefits and Side ... - Seattle Weekly - December 1st, 2023
- 'There is a Scientific Fraud Epidemic' - Slashdot - Slashdot - December 1st, 2023
- 15 Best Hydrating Serums to Soothe Any Skin Type 2023 - Town & Country - December 1st, 2023
- Innovations in Cosmetic Dermatology: A Glimpse into the Future - APN News - December 1st, 2023
- FDA Probes New Cases of Cancer That May Stem From Cancer Cell ... - MedCity News - November 29th, 2023
- Use of plant stem cells in topical formulations on the rise - CosmeticsDesign.com USA - November 29th, 2023
- Stem cell-based treatment controls blood sugar in people with Type ... - EurekAlert - November 29th, 2023
- Biologics Market is projected to grow at a CAGR of 8.5% by 2034: Visiongain - Yahoo Finance - November 29th, 2023
- Scientists devise new technique that can pinpoint the causes and ... - EurekAlert - November 29th, 2023
- Global Advanced Therapy Medicinal Products Market is on the brink ... - PharmiWeb.com - November 29th, 2023
- Introducing Orgavalue - The 2023 EIT InnoStars Awards winner - EU-Startups - November 29th, 2023
- Episode 160: Euan Ashley discusses precision medicine and the ... - IHMC - November 29th, 2023
- Is Phenq Right For You? Review The Facts Before Making a ... - Vashon-Maury Island Beachcomber - November 27th, 2023
- Cavityn Reviews - Does It Work? Cheap Scam or Effective ... - The Daily World - November 25th, 2023
- Trend Hunting With Beautystreams At Cosmoprof Asia 2023 - BeautyMatter - November 25th, 2023
- FDA Considers First CRISPR Gene Editing Treatment That May ... - Slashdot - November 25th, 2023
- How Do Plants Determine Where the Light Is Coming From? - Lab Manager Magazine - November 25th, 2023
- Deaths From Coal Pollution Have Dropped, But Emissions May be ... - Slashdot - November 25th, 2023
- Stem cell-based therapies for stroke in newborns - Cochrane - November 23rd, 2023
- Dr Leslie on Outpatient CAR T-Cell Therapy Programs for ... - OncLive - November 23rd, 2023
- Human Milk-Based Therapy May Be Beneficial in Blood Cancers - Curetoday.com - November 23rd, 2023
- Oncological Horizons: The Synergy of Medical and Surgical ... - Cureus - November 23rd, 2023
- Human and environmental safety of carbon nanotubes across their ... - Nature.com - November 23rd, 2023
- Immix Biopharma to Host KOL Event to Discuss its BCMA-Targeted ... - BioSpace - November 23rd, 2023
- #HearTheMarsdenKids call on NHS London to reconsider cancer ... - Metro.co.uk - November 23rd, 2023
- Diagnosis and Management of Cardiovascular Risk in Patients with ... - Dove Medical Press - November 23rd, 2023
- BioLineRx Reports Third Quarter 2023 Financial Results and ... - PR Newswire - November 21st, 2023
- Why our Award Winners Beauty Box is the ultimate beauty gift (for ... - Yahoo Singapore News - November 21st, 2023
- SightCare Reviews - Is Official Website for Sight Care Legit to Try or ... - Vashon-Maury Island Beachcomber - November 21st, 2023
- Legend Biotech Reports Third Quarter 2023 Results and Recent ... - StreetInsider.com - November 21st, 2023
- Lorenzo's Oil: Can It Really Treat ALD? - Verywell Health - November 19th, 2023
- Doctor Says Living To 120 By End Of Decade Is Possible What's the Secret? - Benzinga - November 19th, 2023
- The week in pharma: action, reaction and insight week to ... - The Pharma Letter - November 19th, 2023
- Race Cannot Be Used To Predict Heart Disease, Scientists Say ... - Slashdot - November 19th, 2023
- SpaceX's Starship Reaches Outer Space Before Intentional ... - Slashdot - November 19th, 2023
- Mesenchymal Stem Cells Market is projected to reach USD 3,319 million by 2030 according to a new research r... - WhaTech Technology and Markets News - November 17th, 2023
- LMRUK: Protecting the next generation through cord blood - Charity Today News - November 17th, 2023
- Anti-aging molecule discovered that extends lifespan - Earth.com - November 17th, 2023
- Montana State researcher envisions living building materials that ... - Montana State University - November 17th, 2023
- OxyHelp Explores the Benefits of Hyperbaric Oxygen Therapy for ... - StreetInsider.com - November 15th, 2023
- Health benefits of bone marrow - Pakistan Observer - November 15th, 2023
- Evolving the standard of care: What is next for functional ... - NeuroNews International - November 15th, 2023
- Affimed Reports Third Quarter 2023 Financial Results and ... - BioSpace - November 15th, 2023
- Meet the World's First Whole-Eye Transplant Recipient - TIME - November 15th, 2023
- Calidi Biotherapeutics Reports Third Quarter 2023 Operating and ... - Business Wire - November 15th, 2023
- 10 Asia-Pacific biotech companies leading innovation in the region - Labiotech.eu - November 15th, 2023
- Fitspresso Reviews (November Update) Natural Ingredients That ... - Bainbridge Island Review - November 15th, 2023
- 2seventy bio Reports Third Quarter Financial Results and Recent ... - Business Wire - November 15th, 2023
- Japan To Create $6.6 Billion Fund To Develop Outer Space Industry ... - Slashdot - November 15th, 2023
- Be The Match, Healthcare Marketing Impact Awards 2023 - Ad Age - November 13th, 2023
- Medicare coverage saves lives. Enrolling shouldn't be this ... - Kevin MD - November 13th, 2023
- Future Ocean Foods: 36 Global Alt-Seafood Startups Form Association To Tackle Overfishing, Microplastics & More - Green Queen Media - November 13th, 2023
- Orchard Therapeutics Reports Third Quarter 2023 Financial Results ... - StreetInsider.com - November 13th, 2023
- Celebrity doctor reveals Hollywoods hidden trend of stem cell antiaging therapies - Longevity.Technology - November 11th, 2023
- Amazon Expands Healthcare Push With One Medical Benefits For ... - Slashdot - November 11th, 2023
- Bene Meat Technologies becomes the first to receive EU approval ... - Pet Food Processing - November 11th, 2023
- FDA Grants Orphan Drug Designation to MAIA Biotechnology for THIO as a Treatment for Glioblastoma - Yahoo Finance - November 11th, 2023
- MaaT Pharma Provides Third Quarter 2023 Business Update and ... - Business Wire - November 11th, 2023
- IN8bio Reports Third Quarter 2023 Financial Results and Provides ... - GlobeNewswire - November 11th, 2023
- Fast Lean Pro Reviews - Overpriced or Optimal Ingredients That ... - Journal of the San Juan Islands - November 11th, 2023
- Fate Therapeutics Reports Third Quarter 2023 Financial Results and ... - GlobeNewswire - November 11th, 2023
- Worlds first whole-eye and partial face transplant gives Arkansas man new hope - CNN - November 9th, 2023
- Glowing Fingertips And Green Eyes: First-of-Its-Kind Monkey ... - ScienceAlert - November 9th, 2023
- 10 Natural Body Scrubs That Exfoliate And Invigorate My Skin - PINKVILLA - November 9th, 2023
- CRISPR Therapeutics Provides Business Update and Reports Third ... - StreetInsider.com - November 9th, 2023
- Fate Therapeutics Reports Third Quarter 2023 Financial Results and ... - StreetInsider.com - November 9th, 2023
Recent Comments